MacroGenics

MacroGenics is a biopharmaceutical company focused on discovering and developing antibody-based therapeutics designed to modulate the human immune response for the treatment of cancer. The company has a pipeline of product candidates in human clinical testing that have been created primarily using its proprietary technology platforms, which also have applicability across other therapeutic domains, including autoimmune disorders and infectious disease. The company's primary clinical product candidate is margetuximab, a monoclonal antibody that targets human epidermal growth factor receptor 2-expressing tumors, including certain types of breast and gastroesophageal cancers.
  • TickerMGNX
  • ISINUS5560991094
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

ValuEngine Rating and Forecast Report for MGNX

MarketLine Department

Actinium Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Actinium Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Actinium Pharmaceuticals, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its c...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch